Physician profile
James B Rounder
NPI 1639140163
$600.76
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $330 · 2020: $110 · 2021: $140 · 2022: $20.52.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $207.38 | 2019 | |
| Abbvie INC. | $61.03 | 2020-2021 | |
| Urovant Sciences INC | $52.36 | 2021-2022 | |
| Intuitive Surgical, INC. | $49.93 | 2020 | |
| Boston Scientific Corporation | $29.65 | 2019 | |
| Endo Pharmaceuticals INC. | $29.54 | 2019 | |
| Janssen Biotech, INC. | $27.38 | 2020 | |
| Allergan, INC. | $26.83 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $22.54 | 2019 | |
| Laborie Medical Technologies Corp. | $20.09 | 2020 | |
| Acerus Pharmaceuticals Corporation | $18.88 | 2021 | |
| Rgh Enterprises LLC | $16.99 | 2019 | |
| Clarus Therapeutics INC. | $14.33 | 2021 | |
| Pfizer INC. | $12.13 | 2019 | |
| Antares Pharma, INC. | $11.70 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Rounder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.